Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel J Walker

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Science (New York, N.Y.)|April 20, 2002
Tech.Sight. A technique whose time has comeNigel J Walker
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 14, 2007
Unraveling the complexities of the mechanism of action of dioxinsNigel J Walker
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
Complexities in understanding the nature of the dose-response for dioxins and related compoundsNigel J Walker, Jae-Ho Yang
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 27, 2009
A 21st century paradigm for evaluating the health hazards of nanoscale materials?Nigel J Walker, John R Bucher
Cardiovascular Toxicology|February 17, 2007
Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin) enhances triggered afterdepolarizations in rat ventricular myocytesAn Xie, Nigel J Walker, Desuo Wang
Clinical Pharmacology and Therapeutics|May 11, 2018
Getting to the Root of the Matter: Challenges and Recommendations for Assessing the Safety of Botanical Dietary SupplementsCynthia V Rider, Nigel J Walker, Suramya Waidyanatha
Environmental Health Perspectives|December 16, 2004
Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expressionChad M Vezina, Nigel J Walker, James R Olson
Toxicology and Applied Pharmacology|January 23, 2004
Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compoundsHiroyoshi Toyoshiba, Nigel J Walker, A John Bailer, et al.
Toxicology and Applied Pharmacology|August 14, 2003
Area under the curve as a dose metric for promotional responses following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposureAmy H Kim, Michael C Kohn, Abraham Nyska, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2002
Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responsesAmy H Kim, Michael C Kohn, Christopher J Portier, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Science (New York, N.Y.)|April 20, 2002
Tech.Sight. A technique whose time has comeNigel J Walker
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 14, 2007
Unraveling the complexities of the mechanism of action of dioxinsNigel J Walker
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
Complexities in understanding the nature of the dose-response for dioxins and related compoundsNigel J Walker, Jae-Ho Yang
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 27, 2009
A 21st century paradigm for evaluating the health hazards of nanoscale materials?Nigel J Walker, John R Bucher
Cardiovascular Toxicology|February 17, 2007
Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin) enhances triggered afterdepolarizations in rat ventricular myocytesAn Xie, Nigel J Walker, Desuo Wang
Clinical Pharmacology and Therapeutics|May 11, 2018
Getting to the Root of the Matter: Challenges and Recommendations for Assessing the Safety of Botanical Dietary SupplementsCynthia V Rider, Nigel J Walker, Suramya Waidyanatha
Environmental Health Perspectives|December 16, 2004
Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expressionChad M Vezina, Nigel J Walker, James R Olson
Toxicology and Applied Pharmacology|January 23, 2004
Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compoundsHiroyoshi Toyoshiba, Nigel J Walker, A John Bailer, et al.
Toxicology and Applied Pharmacology|August 14, 2003
Area under the curve as a dose metric for promotional responses following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposureAmy H Kim, Michael C Kohn, Abraham Nyska, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2002
Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responsesAmy H Kim, Michael C Kohn, Christopher J Portier, et al.
Pageof 7